As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
A global plan to save coral reefs from complete eradication caused by climate change, pollution and poor fishing practices launched today at The Economist World Ocean Summit in Bali. The initiative, called 50 Reefs, brings together leading ocean, climate and marine scientists as well as conservation practitioners from around the world to develop a list of the 50 most critical coral reefs to protect.
50 Reefs will be the first global plan to save the most biodiverse ecosystem on the planet. The final list and corresponding initiatives, to be announced later this year, will raise awareness of the increasing severity of climate change impacts on the ocean and catalyze the global action and investment required to protect these important reef systems for the future.
The launch comes at a perilous moment for coral reefs, as current estimates indicate that 90 percent will disappear by 2050. A unique philanthropic coalition of innovators in business, technology and government are supporting 50 Reefs, led by Bloomberg Philanthropies with The Tiffany & Co. Foundation and The Paul G. Allen Family Foundation, with the aim of preventing the worst economic, social, and environmental impacts of this enormous crisis.
To view the multimedia release go to:
https://www.multivu.com/players/English/8043751-the-ocean-agency-50-reefs-initiative-coral-conservation/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion about the latest best practices and uses for injectables including the newest FDA-approved options at The Aesthetic Meeting today in Montreal, Quebec Canada.
The panel discussed the latest advances, including the ways various dermal fillers can be utilized to produce optimal results for targeted areas. There are thirteen FDA-approved dermal fillers on the market to-date, providing aesthetic plastic surgeons with the ability to customize anti-aging treatments to patients’ needs. “The filler choices are dictated by a patient’s unique aging pattern, the anatomical area to be treated and physiochemical properties,” explains ASAPS member, Dr. Z. Paul Lorenc.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310753-asaps-facial-rejuvenation-injectables/
It’s the time of year when the automotive universe turns its attention to the heart of the industry, as all roads lead to Detroit in January. The North American International Auto Show (NAIAS) encourages its global journalist audience to begin preparations to attend Press Preview, Jan. 11-12, 2016, at the completely transformed Cobo Center. Widely considered one of the most important automotive events on the planet, NAIAS is consistently the strategic choice of global automakers to launch their new products and automotive technology, and the 2016 show is no exception.
“The industry is truly firing on all cylinders, and that will be reflected at this year’s show,” said Paul Sabatini, 2016 NAIAS Chairman. “Attendees to the 2016 NAIAS will see the most global reveals of any auto show in North America, and will experience them amidst automaker exhibits that are either completely new or significantly enhanced for the upcoming show.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7699851-detroit-2016-naias/
